Post-Authorization Safety Studies is a type of observational or interventional epidemiological study conducted after a medicinal product has received regulatory approval, designed to systematically assess the safety profile of the product in real-world use and to identify, characterize, or quantify previously unknown or incompletely understood safety concerns.
46
Publications
1.8K
Citations
249
Authors
156
Institutions
Publications per year
2017–2026
16
Publications
46
A. J. van der Lely, Beverly M. K. Biller, Thierry Brue et al. · The Journal of Clinical Endocrinology & Metabolism · 2012 · 251 citations · Full text
Vinay K. Rathi, Harlan M. Krumholz, Frederick A. Masoudi et al. · JAMA · 2015 · 109 citations
1–5 of 46
Authors
249
- SM
2
h-index
- SB
2
h-index
- DS
2
h-index
- CM
1
h-index
- JJ
1
h-index
1–5 of 249
Institutions
156
Karolinska Institutet
Stockholm, Sweden
3 h-index
3 publications
121 citations
United States Food and Drug Administration
Silver Spring, United States
3 h-index
10 publications
176 citations
Erasmus MC
Rotterdam, The Netherlands
2 h-index
2 publications
281 citations
IQVIA (United Kingdom)
London, United Kingdom
2 h-index
6 publications
281 citations
Medicines Evaluation Board
Utrecht, Netherlands
2 h-index
8 publications
352 citations
University Medical Center Utrecht
Utrecht, The Netherlands
2 h-index
4 publications
136 citations
Robert Wood Johnson Foundation
Princeton, United States
2 h-index
3 publications
246 citations
Tel Aviv University
Tel Aviv, Israel
2 h-index
5 publications
64 citations
1–8 of 156
Venues
- Drug Safety
6 publications · 242 citations
6
h-index
- New England Journal of Medicine
NEJM · 3 publications · 185 citations
3
h-index
- Choice Reviews Online
CRO · 2 publications · 93 citations
2
h-index
- JAMA
2 publications · 137 citations
2
h-index
- Journal of the Royal Society of Medicine
JRSM · 2 publications · 130 citations
2
h-index
1–5